ProShare Advisors’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238K | Buy |
10,284
+771
| +8% | +$17.8K | ﹤0.01% | 1609 |
|
|
2025
Q1 | $257K | Sell |
9,513
-871
| -8% | -$23.5K | ﹤0.01% | 1515 |
|
|
2024
Q4 | $556K | Buy |
10,384
+2,003
| +24% | +$107K | ﹤0.01% | 1213 |
|
|
2024
Q3 | $381K | Buy |
8,381
+2,863
| +52% | +$130K | ﹤0.01% | 1307 |
|
|
2024
Q2 | $231K | Sell |
5,518
-1,137
| -17% | -$47.6K | ﹤0.01% | 1458 |
|
|
2024
Q1 | $251K | Buy |
+6,655
| New | +$251K | ﹤0.01% | 1536 |
|